Vermont joins Alaska, California, Colorado, the District of Columbia, Maine, Massachusetts, Nevada, Oregon, and Washington in legalizing the adult possession and use of marijuana. It is the first state to enact legalization via an act of the legislature rather than by the passage of a voter initiative.
Mark another victory down for 2018. Oklahoma just became the 30th state to approve medical marijuana, as voters approved SQ 788 57% to 43%! Despite an advertising blitz from opponents in the final days before the election, the Yes on 788 team emerged victorious. Thanks the campaign’s efforts — and the voters of Oklahoma — … Continue reading Compassion wins: Oklahoma legalizes medical marijuana!
Regulators at the US Food and Drug Administration today granted market approval for Epidiolex, a prescription medicine containing a standardized formulation of plant-derived cannabidiol (CBD), for the explicit treatment of two rare forms of severe epilepsy: Lennox-Gastaut syndrome and Dravet syndrome.
The Health Commissioner of New York, Howard Zucker, recently announced that a long-awaited study by the Cuomo administration will recommend the legalization and regulation of marijuana for adult use. The study is believed to be at least partly in response to gubernatorial primary candidate Cynthia Nixon’s strong support of marijuana legalization. Mr. Zucker also announced … Continue reading NY Health Dept. will expand medical program; looks favorably toward adult use
Former Missouri Supreme Court Chief Justice and former Dean of the St. Louis University Law School, Michael A. Wolff, announces support of the New Approach Missouri Medical Marijuana Initiative.
In a surprise joint press conference, Cyrus Vance Jr. and Eric Gonzalez, the respective District Attorneys of Manhattan and Brooklyn in New York City, both announced that with limited exception low-level marijuana-related offenses would no longer be prosecuted.
The frequent use of cannabis is not associated with changes in brain structure, according to data published online ahead of print in the journal Addiction. Authors reported, “[N]ormal variation in cannabis use is statistically unrelated to individual differences in brain morphology as measured by subcortical volume.”